Tag Archive for: diabetes

Results from BIG D-FOOT study using STIMULAN® when treating DFO to be presented at EBJIS 2025

/in

Randomised, double-blinded, controlled BIG D-FOOT study demonstrates that local antibiotic delivery using STIMULAN® significantly reduces post-surgical infective complications in patients with diabetic foot osteomyelitis (DFO) Biocomposites symposium will explore best practice treatment strategies for complex infections and share findings from the BIG D FOOT study Keele, UK, 9 September 2025 – Biocomposites, an international medical […]

Read more

ViCentra Raises $85M to Scale Manufacturing and Accelerate Market Penetration of Kaleido Insulin Patch Pump

/in

Led by new investor Innovation Industries, with matching contributions from existing investors, Partners in Equity and Invest-NL, the $85M round also drew support from EQT Life Sciences and Health Innovations, demonstrating strong confidence in ViCentra’s next phase of growth Fresh capital fuels scale-up, regulatory pathway, and commercialization of Kaleido 2, the world’s smallest, lightest, and […]

Read more

Atrogi announces Cell paper highlighting transformative potential of muscle-targeted therapy in metabolic disease

/in

Atrogi’s breakthrough discovery enables chronic use of next-generation, highly selective β2-agonists for the first time in metabolic disease First-in-class oral therapy ATR-258 mimics the effects of exercise – driving fat loss, increasing muscle, and improving metabolism – with broad potential in obesity, diabetes, and age-related muscle loss ATR-258 is set to enter Phase 2 trials […]

Read more

Experienced Industry Leader Tom Arnold Appointed as Chief Executive Officer of ViCentra

/in

Experienced MedTech leader to scale manufacturing, drive European expansion, and position the company to enter the US market with the Kaleido insulin patch pump AID system Utrecht, The Netherlands – February 26, 2025 ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest, and most precise insulin patch pump and automated insulin delivery […]

Read more

Liva Healthcare acquires Momenta, and secures funding from new and existing investors to drive growth

/in

Purchase of UK-based Discover Momenta and Momenta Newcastle (‘Momenta’) for undisclosed amount Acquisition will significantly increase Liva’s reach and reflects strong synergies, as both companies provide evidence-based programmes for patients with lifestyle-related chronic conditions Funding secured from Nupo / IBLGroup, a new strategic investor, and existing investors ‍ Copenhagen, Denmark, and London, UK, 5 February […]

Read more